Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion type Assertion NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_head.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion wasGeneratedBy ECO_0000203 NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_provenance.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion wasDerivedFrom befree-20150227 NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_provenance.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion SIO_000772 17854396 NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_provenance.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion evidence source_evidence_literature NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_provenance.
- NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_assertion description "[Forty-eight cancer tissues were divided into three groups: Group 1, 28 primary cancers; Group 2, 7 recurrences capable of trapping (131)I; and Group 3, 13 recurrences incapable of trapping (131)I. mRNA levels of thyroid genes (sodium/iodide symporter NIS, thyroglobulin, thyroperoxidase and pendrin) and glycolytic metabolism genes (GLUT-1, hexokinase I and II) and BRAF mutations were evaluated in the different groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450401.RACPetki5SAoxj94aAga5wOlLxWZli2D0Uh-uZ_62yCbk130_provenance.